Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Zealand Pharma Ord Shs ZLDPF

Healthcare Biotechnology
Zealand Pharma A/S is a Denmark-based biotechnology company. The Company is focused on the discovery, design and development of peptide-based medicines for metabolic and gastrointestinal diseases and other rare disease areas with unmet medical needs. The Company's peptide-based product candidates includes clinical development, registration and, potentially, commercialization. Its pipeline... see more

Recent & Breaking News (PINL:ZLDPF)

Zealand Pharma Announces Voluntary Delisting of American Depositary Shares from the U.S.-Based Nasdaq Global Select Market

GlobeNewswire August 8, 2022

Zealand Pharma Hosts Conference Call on August 11 at 4 pm CET (10am ET) to Present Second Quarter Results for 2022

GlobeNewswire August 4, 2022

Total number of shares and voting rights in Zealand Pharma at June 30, 2022

GlobeNewswire June 30, 2022

Transactions in Zealand Pharma A/S securities by persons discharging managerial responsibilities

GlobeNewswire June 15, 2022

Zealand Pharma major shareholder announcement: Credit Suisse Group AG, 2022

GlobeNewswire June 10, 2022

Zealand Pharma Presents Data from Phase 1 Trial of Dapiglutide at the 82nd Annual American Diabetes Association Scientific Sessions and Announces Dapiglutide to Move into Phase 2 Trial for Obesity

GlobeNewswire June 6, 2022

Zealand Pharma completes registration of capital increase

GlobeNewswire June 3, 2022

Zealand Pharma to Participate in Upcoming Investor Conferences

GlobeNewswire June 3, 2022

Zealand Pharma Announces Appointment of David M. Kendall, M.D., as Chief Medical Officer

GlobeNewswire June 2, 2022

Zealand Pharma announces directed issue and private placement corresponding to approx. 6.6 % of existing share capital

GlobeNewswire June 1, 2022

Transactions in Zealand Pharma A/S securities by persons discharging managerial responsibilities

GlobeNewswire May 31, 2022

Zealand Pharma Announces Multiple Presentations at the 82nd Annual American Diabetes Association Scientific Sessions, Including Initial Clinical Data on GLP-1/GLP-2 Dual Agonist Dapiglutide

GlobeNewswire May 31, 2022

Transactions in Zealand Pharma A/S securities by persons discharging managerial responsibilities

GlobeNewswire May 25, 2022

Zealand Pharma Announces Positive Results from Phase 3 Trial of Dasiglucagon in Pediatric Patients with Congenital Hyperinsulinism (CHI)  

GlobeNewswire May 19, 2022

Zealand Pharma Announces Asset Purchase Agreement with MannKind Corporation for V-Go® Insulin Delivery Device

GlobeNewswire May 17, 2022

Transactions in Zealand Pharma A/S securities by persons discharging managerial responsibilities [CORRECTED]

GlobeNewswire May 12, 2022

Transactions in Zealand Pharma A/S securities by persons discharging managerial responsibilities

GlobeNewswire May 12, 2022

Zealand Pharma Provides Update on Refocused Strategy Prioritizing Research and Development

GlobeNewswire May 12, 2022

Zealand Pharma major shareholder announcement: Credit Suisse Group AG, 2022

GlobeNewswire May 10, 2022

Zealand Pharma Amends Financing Agreement with Oberland Capital as Part of Company's Refocused Strategy

GlobeNewswire May 9, 2022